Mengqing Xiao Selected Research

Paclitaxel (Taxol)

6/2023	circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53.
1/2019	The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mengqing Xiao Research Topics

Disease

16	Neoplasms (Cancer) 12/2022 - 01/2017
7	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2017
2	Nasopharyngeal Carcinoma 06/2023 - 01/2020
2	Carcinogenesis 12/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2019
2	Adenocarcinoma of Lung 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2017 - 01/2017
1	Cardiotoxicity 11/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022
1	Hepatitis 01/2022
1	Enteritis 07/2021
1	Mucositis 07/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017
1	Liver Neoplasms (Liver Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 01/2021 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 01/2020
3	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
2	ran-binding protein 2IBA 02/2024 - 07/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	Competitive Endogenous RNAIBA 01/2021 - 11/2020
2	Ligases (Synthetase)IBA 01/2020 - 01/2020
2	UbiquitinIBA 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2017
2	Cardiolipins (Cardiolipin)IBA 01/2019 - 01/2017
2	LipidsIBA 10/2017 - 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023
1	Circular RNAIBA 06/2023
1	Protein Isoforms (Isoforms)IBA 12/2022
1	Serine (L-Serine)FDA Link 12/2022
1	Arginine (L-Arginine)FDA Link 12/2022
1	RNA Splicing FactorsIBA 12/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2022
1	purineIBA 01/2022
1	AlbuminsIBA 07/2021
1	ElementsIBA 07/2021
1	SeleniumIBA 07/2021
1	Serpentine Asbestos (Chrysotile)IBA 06/2021
1	AntigensIBA 06/2021
1	N-methyladenosineIBA 01/2021
1	6-methyladenineIBA 01/2021
1	LigandsIBA 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2021
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	CholesterolIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	ClayIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	StaurosporineIBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
3	Immunotherapy 10/2021 - 01/2020
1	Fecal Microbiota Transplantation 07/2021
1	Drug Therapy (Chemotherapy) 07/2021
1	Radiotherapy 01/2021